GRANTS

123 RESULTS

To submit a grant posting, please fill out our web form or download the form so that you can email us at grants@alzforum.org. List the sponsor name, amount, due date, and contact information. This is a free service.

Please Note: We remove grant postings after 6 months. If you would like your listing to be posted longer or taken down sooner, please contact us at grants@alzforum.org.

Development and Commercialization of Technologies to Create, Characterize or Improve Animal Models of Human Disease (R43/R44)

Sponsor: Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs

Award: Total funding support (direct costs, indirect costs, fee) normally may not exceed $150,000 for Phase I awards and $1,000,000 for Phase II awards. With appropriate justification from the applicant, Congress will allow awards to exceed these amounts by up to 50 percent ($225,000 for Phase I and $1,500,000 for Phase II).

Due Date: Standard dates apply, by 5 p.m. local time of applicant organization. (Note new SBIR/STTR standard due dates.)

Mentored Patient-Oriented Research Career Development Award (Parent K23)

Sponsor: National Institutes of Health

Award: The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.

Due Date: Standard dates apply. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

NIH Pathway to Independence Award (Parent K99/R00)

Sponsor: National Institutes of Health

Award: The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.

Due Date: Standard dates apply. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

ADDF/NIH RFP

Sponsor: Alzheimer's Drug Discovery Foundation

Award: Varies

Due Date: Proposals accepted on a rolling basis

Bioengineering Research Partnerships (U01)

Sponsor: National Institute of Biomedical Imaging and Bioengineering, National Cancer Institute, National Eye Institute, National Institute on Alcohol Abuse and Alcoholism, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institute on Drug Abuse, National Institute of Environmental Health Sciences, National Institute of Neurological Disorders and Stroke

Due Date: September 13, 2017, May 8, 2018, September 13, 2018, by 5 p.m. local time of applicant organization.

Drug Discovery For Nervous System Disorders (R01)

Sponsor: National Institute of Mental Health, National Institute on Alcohol Abuse and Alcoholism, National Institute on Drug Abuse

Due Date: Standard dates apply by 5 p.m. local time of applicant organization

Revision Applications for Validation of Mobile/Wireless Health Tools for Measurement and Intervention (R01)

Sponsor: Office of Behavioral and Social Science Research, National Cancer Institute, National Institute of Biomedical Imaging and Bioengineering, National Institute on Deafness and Other Communication Disorders, National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Mental Health

Due Date: Standard dates apply by 5 p.m. local time of applicant organization

Drug Discovery For Nervous System Disorders (R21)

Sponsor: National Institute of Mental Health, National Institute on Alcohol Abuse and Alcoholism, National Institute on Drug Abuse

Due Date: Standard dates apply by 5 p.m. local time of applicant organization

BRAIN Initiative: Non-Invasive Neuromodulation - Mechanisms and Dose/Response Relationships for Targeted CNS Effects (R01)

Sponsor: National Institute of Mental Health, National Center for Complementary and Integrative Health, National Eye Institute, National Institute on Aging, National Institute on Alcohol Abuse and Alcoholism, National Institute of Biomedical Imaging and Bioengineering, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institute on Drug Abuse, National Institute on Deafness and Other Communication Disorders, National Institute of Neurological Disorders and Stroke

Award: The issuing IC and partner components intend to commit an estimated total of $8 million to fund 10-20 awards.

Due Date: Not Applicable

Current Filters

No filters selected

Filter By